Results 21 to 30 of about 1,347 (176)

Exploring New Kingdoms: The Role of Extracellular Vesicles in Oxi-Inflamm-Aging Related to Cardiorenal Syndrome [PDF]

open access: yesAntioxidants, 2021
The incidence of age associated chronic diseases has increased in recent years. Although several diverse causes produce these phenomena, abundant evidence shows that oxidative stress plays a central role. In recent years, numerous studies have focused on
Cristina Mas-Bargues   +4 more
doaj   +4 more sources

The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets

open access: yesCells, 2021
Senescence is linked to a wide range of age-associated diseases and physiological declines. Thus, senotherapeutics are emerging to suppress the detrimental effects of senescence either by senomorphics or senolytics.
Martina Rossi, Kotb Abdelmohsen
doaj   +2 more sources

Caffeic Acid Acts as a Potent Senomorphic and Alleviates Inflammation and Lung Fibrosis by Covalently Targeting Annexin A5 Protein in Mice [PDF]

open access: yesExploration
The accumulation of senescent cells and their secretion of senescence‐associated secretory phenotype (SASP) play important roles in the pathogenesis of idiopathic pulmonary fibrosis (IPF).
Yinhua Zhu   +14 more
doaj   +2 more sources

Senotherapeutic Effect of Retinaldehyde and Hyaluronate Fragments in Dermatoporosis

open access: yesDermatopathology (Basel, Switzerland), 2023
Cellular senescence is one of the important mechanisms of skin aging. In a recent study, we have shown that in patients with dermatoporosis, an extreme senescence condition of the skin, cells positive for p16Ink4a, a biomarker of senescence, were ...
Jean-Hilaire Saurat   +2 more
exaly   +3 more sources

Lens epithelial cells senescence in cataract pathogenesis and emerging therapeutic opportunities [PDF]

open access: yesFrontiers in Cell and Developmental Biology
Lens epithelial cells (LECs) senescence is a central pathogenic mechanism in cataract formation, driven by a variety of chronic stressors such as oxidative damage, UV radiation, metabolic disturbances, and mechanical strain.
Liangning Cui   +7 more
doaj   +2 more sources

Cellular senescence: Molecular signatures and cellular remodeling. [PDF]

open access: yesFEBS Open Bio
Cellular senescence, a state of stable cell‐cycle arrest accompanied by profound metabolic and secretory changes, has emerged as a central hallmark of aging and a key contributor to age‐associated diseases. Despite the great progress in understanding the characteristics, the underlying molecular mechanisms, and the role of senescent cells in several ...
Kletsas D.
europepmc   +2 more sources

Aging and oral squamous cell carcinoma development: the role of cellular senescence [PDF]

open access: yesFrontiers in Oral Health, 2023
The gradual accumulation and inadequate renewal of senescent cells over time drive organismal aging. Senescent cells undergo altered gene expression and release inflammatory mediators collectively termed the senescence-associated secretory phenotype ...
Sven Eric Niklander   +3 more
doaj   +3 more sources

Senopathies—Diseases Associated with Cellular Senescence

open access: yesBiomolecules, 2023
Cellular senescence describes a stable cell cycle arrest state with a characteristic phenotype. Senescent cells accumulate in the human body during normal aging, limiting the lifespan and promoting aging-related, but also several non-related, pathologies.
Oleh Lushchak   +2 more
doaj   +2 more sources

Translation of Cellular Senescence to Novel Therapeutics: Insights From Alternative Tools and Models [PDF]

open access: yesFrontiers in Aging, 2022
Increasing chronological age is the greatest risk factor for human diseases. Cellular senescence (CS), which is characterized by permanent cell-cycle arrest, has recently emerged as a fundamental mechanism in developing aging-related pathologies.
Nurcan Inci   +6 more
doaj   +2 more sources

Is it the time of seno-therapeutics application in cardiovascular pathological conditions related to ageing? [PDF]

open access: yesCurrent Research in Pharmacology and Drug Discovery, 2021
It rates that in 2030, the cardiovascular diseases (CVD) will result in 40% of all deaths and rank as the leading cause. Thus, the research of appropriate therapies able to delay or retard their onset and progression is growing. Of particular interest is
Carmela Rita Balistreri   +2 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy